Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 1
2022 3
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Microbiome in Multiple Sclerosis; Where Are We, What We Know and Do Not Know.
Boziki MK, Kesidou E, Theotokis P, Mentis AA, Karafoulidou E, Melnikov M, Sviridova A, Rogovski V, Boyko A, Grigoriadis N. Boziki MK, et al. Among authors: karafoulidou e. Brain Sci. 2020 Apr 14;10(4):234. doi: 10.3390/brainsci10040234. Brain Sci. 2020. PMID: 32295236 Free PMC article. Review.
The trimebutine effect on Helicobacter pylori-related gastrointestinal tract and brain disorders: A hypothesis.
Boziki M, Grigoriadis N, Papaefthymiou A, Doulberis M, Polyzos SA, Gavalas E, Deretzi G, Karafoulidou E, Kesidou E, Taloumtzis C, Theotokis P, Sofou E, Katsinelos P, Vardaka E, Fludaras I, Touloumtzi M, Koukoufiki A, Simeonidou C, Liatsos C, Kountouras J. Boziki M, et al. Among authors: karafoulidou e. Neurochem Int. 2021 Mar;144:104938. doi: 10.1016/j.neuint.2020.104938. Epub 2021 Jan 31. Neurochem Int. 2021. PMID: 33535070 Review.
Impact of Helicobacter pylori and metabolic syndrome on mast cell activation-related pathophysiology and neurodegeneration.
Kountouras J, Boziki M, Kazakos E, Theotokis P, Kesidou E, Nella M, Bakirtzis C, Karafoulidou E, Vardaka E, Mouratidou MC, Kyrailidi F, Tzitiridou-Chatzopoulou M, Orovou E, Giartza-Taxidou E, Deretzi G, Grigoriadis N, Doulberis M. Kountouras J, et al. Among authors: karafoulidou e. Neurochem Int. 2024 Mar 18:105724. doi: 10.1016/j.neuint.2024.105724. Online ahead of print. Neurochem Int. 2024. PMID: 38508416 Review.
Ocrelizumab in Patients with Active Primary Progressive Multiple Sclerosis: Clinical Outcomes and Immune Markers of Treatment Response.
Boziki M, Bakirtzis C, Sintila SA, Kesidou E, Gounari E, Ioakimidou A, Tsavdaridou V, Skoura L, Fylaktou A, Nikolaidou V, Stangou M, Nikolaidis I, Giantzi V, Karafoulidou E, Theotokis P, Grigoriadis N. Boziki M, et al. Among authors: karafoulidou e. Cells. 2022 Jun 17;11(12):1959. doi: 10.3390/cells11121959. Cells. 2022. PMID: 35741088 Free PMC article.
Blood Metabolomics May Discriminate a Sub-Group of Patients with First Demyelinating Episode in the Context of RRMS with Increased Disability and MRI Characteristics Indicative of Poor Prognosis.
Boziki M, Pechlivanis A, Virgiliou C, Bakirtzis C, Sintila SA, Karafoulidou E, Kesidou E, Theotokis P, Nikolaidis I, Theodoridis G, Gika H, Grigoriadis N. Boziki M, et al. Among authors: karafoulidou e. Int J Mol Sci. 2022 Nov 23;23(23):14578. doi: 10.3390/ijms232314578. Int J Mol Sci. 2022. PMID: 36498904 Free PMC article.